TickerFacts.

Drugs Made In America Acquisition Corp. (DMAA): Total Assets

Annual figures by period end, from SEC filings.

$239.92M
As of 2025-12-31
$146.90M
As of 2026-06-30
2024-12-31: $550.8K2025-12-31: $239.92M$239.92M
2024-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$239.92Mn/m2026-04-15, Balance as of period end
2024-12-31$550.8Kn/a2026-04-15, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Drugs Made In America Acquisition Corp. (DMAA)2025-12-31$239.92Mn/m
Fifth Era Acquisition Corp I (FERA)2025-12-31$238.58Mn/m
Archimedes Tech SPAC Partners II Co. (ATII)2025-12-31$241.35Mn/m
Roman DBDR Acquisition Corp. II (DRDB)2025-12-31$241.51M+19.1%
Sizzle Acquisition Corp. II (SZZL)2025-12-31$237.96Mn/m
Evolution Global Acquisition Corp (EVOX)2025-12-31$242.47Mn/a
Cal Redwood Acquisition Corp. (CRAQ)2025-12-31$236.87Mn/a
Rithm Acquisition Corp. (RAC)2025-09-30$236.87Mn/a
Jackson Acquisition Co II (JACS)2025-12-31$243.18M+3.9%

Compare DMAA, FERA, ATII, DRDB side by side · Screen every company in Blank Checks ↗